US 8785377
Tetrazolyl macrocyclic hepatitis C serine protease inhibitors
granted A61KA61K31/13A61K31/41
Quick answer
US patent 8785377 (Tetrazolyl macrocyclic hepatitis C serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/13, A61K31/41, A61K31/7056, A61K38/212